CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

Documentation Centre

December 19, 2008: Role of the dysregulated endocannabinoid system in determining cardiometabolic risk.; By Vincenzo Di Marzo, PhD, Istituto di Chimica Biomolecolare Pozzuoli, NA, Italy [9 slides] [0.7 MB]

Presenter's Notes

###SLIDE_NOTES###

See all Slide Sets of Vincenzo Di Marzo, PhD, Istituto di Chimica Biomolecolare Pozzuoli, NA, Italy

Key Words
Metabolism: Animal Studies, Metabolism: Human Studies, Obesity

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.

E-mail address
Confirm E-mail address

Documentation Centre

THANKS FOR DOWNLOADING! WANT MORE?